363-32-6

Basic information

• Product Name: ETHYL 2-FLUORO-4-NITROBENZOATE
• Synonyms: ETHYL 2-FLUORO-4-NITROBENZOATE;Benzoic acid, 2-fluoro-4-nitro-, ethyl ester
• CAS NO: 363-32-6
• Molecular Formula: C₉H₈FNO₄
• Molecular Weight: 213.1625232
• Mol File: 363-32-6.mol
• Article Data: 17

Chemical Properties

• Boiling Point: 326.208°C at 760 mmHg
• Flash Point: 151.086°C
• Appearance: /
• Density: 1.333g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.528
• Storage Temp.: 2-8°C
• CAS DataBase Reference: ETHYL 2-FLUORO-4-NITROBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 2-FLUORO-4-NITROBENZOATE(363-32-6)
• EPA Substance Registry System: ETHYL 2-FLUORO-4-NITROBENZOATE(363-32-6)

Safety Data

• Hazardous Substances Data: 363-32-6(Hazardous Substances Data)

Usage

General Description

Ethyl 2-fluoro-4-nitrobenzoate is an organic compound with the chemical formula C9H8FNO4. It is a pale yellow solid that is commonly used as an intermediate in the production of pharmaceuticals, agrochemicals, and dyes. This chemical is often synthesized through the esterification of 2-fluoro-4-nitrobenzoic acid with ethanol. It is known to have potential toxic effects on aquatic life and has a low solubility in water. Additionally, ethyl 2-fluoro-4-nitrobenzoate has been studied for its potential use as a building block for the development of new drugs and materials due to its unique chemical structure and properties.

InChI:InChI=1/C9H8FNO4/c1-2-15-9(12)7-4-3-6(11(13)14)5-8(7)10/h3-5H,2H2,1H3

Upstream product

• 64-17-5 ethanol 
• 403-23-6 2-fluoro-4-nitrobenzoyl chloride 
• 1427-07-2 2-fluoro-4-nitrotoluene 
• 403-24-7 2-fluoro-4-nitrobenzoic acid 
• 7664-93-9 sulfuric acid 
• 75-03-6 ethyl iodide 

Downstream Products

• 73792-06-0 ethyl-4-amino-2-fluorobenzoate 
• 191469-57-5 ethyl 2-fluoro-4-[(3'-methoxymethoxy-4-bromo-5',6',7',8'-tetrahydro-5',5',8',8'-tetramethylnaphtalen-2'-yl)carbamoyl]benzoate 
• 1323276-32-9 C₂₀H₂₁FN₄O₅ 
• 915391-14-9 C₁₆H₁₃FN₂O₆ 

Relevant articles and documents

RAR-ALPHA COMPOUNDS FOR INFLAMMATORY DISEASE AND MALE CONTRACEPTION

Modulators of retinoid acid receptor-alpha (RARα) of formula (I) are provided herein, as well as pharmaceutical compositions and methods relating thereto.

RETINOID COMPOUND AND PHARMACEUTICAL COMPOSITION

PROBLEM TO BE SOLVED: To provide a novel retinoid compound that is low in teratogenicity, and a pharmaceutical composition containing said retinoid compound. SOLUTION: Provided are a retinoid compound which is a compound represented by the following formula (1) or a salt thereof, and a pharmaceutical composition containing said retinoid compound. In the formula, R1 represents a halogen atom, and R2 and R3 each independently represent a silyl group. SELECTED DRAWING: None COPYRIGHT: (C)2020,JPOandINPIT

N-substituted benzenesulfonyl-substituted benzamide compounds and application thereof to drug preparation

The invention relates toN-substituted benzenesulfonyl-substituted benzamide compounds, crystal forms, pharmaceutically acceptable salts, hydrates, solvates or predrugs of the compounds as well as a preparation method and a pharmaceutical application of th